LIVERTY Trademark

Trademark Overview


On Thursday, November 15, 2012, a trademark application was filed for LIVERTY with the United States Patent and Trademark Office. The USPTO has given the LIVERTY trademark a serial number of 85780089. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, May 17, 2024. This trademark is owned by GOLDEN BIOTECHNOLOGY CORPORATION. The LIVERTY trademark is filed in the Pharmaceutical Products category with the following description:

Adjuvants for medical purposes; antiallergic medicines; anti-cancer preparations; medicinal herbal extracts for medical purposes; pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; dietary and nutritional supplements for medical use; dietary supplements for treating fatigue or liver support; animal feed additive for use as a nutritional supplement for medical purposes; dietary supplements for human consumption or for animals; nutritional addit...
liverty

General Information


Serial Number85780089
Word MarkLIVERTY
Filing DateThursday, November 15, 2012
Status800 - REGISTERED AND RENEWED
Status DateFriday, May 17, 2024
Registration Number4511776
Registration DateTuesday, April 8, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 4, 2013

Trademark Statements


Goods and ServicesAdjuvants for medical purposes; antiallergic medicines; anti-cancer preparations; medicinal herbal extracts for medical purposes; pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; dietary and nutritional supplements for medical use; dietary supplements for treating fatigue or liver support; animal feed additive for use as a nutritional supplement for medical purposes; dietary supplements for human consumption or for animals; nutritional additives in the nature of a dietary supplement for medical purposes for use in foods for human consumption or for animals; animal feed supplements; dietary pet supplements in the form of pet treats; fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; cardiovascular pharmaceuticals; cardiovascular treatment preparations; pharmaceuticals preparations for the treatment of kidney diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 21, 2012
Primary Code005
First Use Anywhere DateTuesday, July 30, 2013
First Use In Commerce DateTuesday, July 30, 2013

Trademark Owner History


Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Taipei City 25147
TW

Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Taipei City
TW

Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Taipei City
TW

Trademark Events


Event DateEvent Description
Monday, November 19, 2012NEW APPLICATION ENTERED
Wednesday, November 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 12, 2013ASSIGNED TO EXAMINER
Thursday, March 14, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, March 14, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, March 14, 2013EXAMINERS AMENDMENT E-MAILED
Thursday, March 14, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 1, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 20, 2013ASSIGNED TO LIE
Wednesday, May 1, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 15, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 4, 2013PUBLISHED FOR OPPOSITION
Tuesday, June 4, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2014TEAS STATEMENT OF USE RECEIVED
Monday, February 17, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 25, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 4, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, July 30, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2014USE AMENDMENT FILED
Monday, February 24, 2014STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 5, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 8, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 28, 2019TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 8, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 12, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, December 1, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, December 1, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, December 1, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, December 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 8, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, May 17, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 17, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, May 17, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, May 17, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, December 23, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, February 2, 2024TEAS SECTION 8 & 9 RECEIVED